CFDE Data Portal | Search KBTBD11

	Label	Description
	KBTBD11 Gene (Entity type)	ENSG00000176595 - kelch repeat and BTB domain containing 11
	KBTBD11 associations Collection (Entity type)	Associations for KBTBD11_associations
	KBTBD11 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	KBTBD11-AS1 Gene (Entity type)	ENSG00000253764 - KBTBD11 antisense RNA 1
	KBTBD11-OT1 Gene (Entity type)	ENSG00000253696 - KBTBD11 overlapping transcript 1
	GSE114492 GSE153671 KMT2D inhibition 6 v 8 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE102505 5 V 0 TUNICAMYCIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE135350 2 V 4 DEXAMETHASONE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE186471 1 V 2 CARNOSOL HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE195663 cisplatin 7 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS

KBTBD11

ENSG00000176595 - kelch repeat and BTB domain containing 11

KBTBD11 associations

Associations for KBTBD11_associations

KBTBD11 associations.tsv

A file from IDG as part of the Harmonizome project

KBTBD11-AS1

ENSG00000253764 - KBTBD11 antisense RNA 1

KBTBD11-OT1

ENSG00000253696 - KBTBD11 overlapping transcript 1

GSE114492 GSE153671 KMT2D inhibition 6 v 8 human dn

A Gene Set from LINCS

GSE102505 5 V 0 TUNICAMYCIN HUMAN DN

A Gene Set from LINCS

GSE135350 2 V 4 DEXAMETHASONE HUMAN UP

A Gene Set from LINCS

GSE186471 1 V 2 CARNOSOL HUMAN DN

A Gene Set from LINCS

GSE195663 cisplatin 7 v 1 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.